Home - Products - Others - Other Targets - 1,3-Dihydroxy-2,7,8-trimethoxy-6-methyl-9,10-anthracenedione

1,3-Dihydroxy-2,7,8-trimethoxy-6-methyl-9,10-anthracenedione

CAS No. 1622982-59-5

1,3-Dihydroxy-2,7,8-trimethoxy-6-methyl-9,10-anthracenedione( ——— )

Catalog No. M38226 CAS No. 1622982-59-5

6,8-Dihydroxy-1,2,7-trimethoxy-3-methylanthraquinone (compound 1) is an anthraquinone α-glucosidase inhibitor (IC50:185 μM), which can be isolated from Cassia seeds.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    1,3-Dihydroxy-2,7,8-trimethoxy-6-methyl-9,10-anthracenedione
  • Note
    Research use only, not for human use.
  • Brief Description
    6,8-Dihydroxy-1,2,7-trimethoxy-3-methylanthraquinone (compound 1) is an anthraquinone α-glucosidase inhibitor (IC50:185 μM), which can be isolated from Cassia seeds.
  • Description
    6,8-Dihydroxy-1,2,7-trimethoxy-3-methylanthraquinone (compound 1) is an anthraquinone α-glucosidase inhibitor (IC50:185 μM), which can be isolated from Cassia seeds.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    IC50: 185 μM (α-Glucosidase)
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    1622982-59-5
  • Formula Weight
    344.32
  • Molecular Formula
    C18H16O7
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Xu YL, et al. Five new anthraquinones from the seed of Cassia obtusifolia. Arch Pharm Res. 2015 Jun;38(6):1054-8.?
molnova catalog
related products
  • [D-Ala2,Hyp4,Tyr5]- ...

    [D-Ala2,Hyp4,Tyr5]- b-Casomorphin (1-5) amide

  • Naratuximab

    Naratuximab emtansine is a humanized monoclonal antibody (Anti-TSPAN26/CD37 Reference Antibody (naratuximab)) that specifically targets CD37 (TSPAN26) and serves as the basis for creating an antibody-drug conjugate (ADC) compound.

  • Obtustatin

    Highly potent integrin α1β1 inhibitor (IC50 = 0.8 nM for α1β1 binding to type IV collagen). Selective for α1β1 over α2β1, αIIbβ3, αvβ3, α4β1, α5β6, α9β1 and α4β7. Inhibits FGF2-stimulated angiogenesis in the chicken chorioallantoic model. Displays antitumor efficacy in a synergistic mouse model of Lewis lung carcinoma; blocks human melanoma growth in nude mice.